What Surgical Esthetics Biomedical does

Surgical Esthetics Biomedical is a privately held dental regenerative biomaterials company founded in 2011 by Dr. Kevin Frawley and headquartered in Northridge, California. It develops, manufactures, and distributes an allograft-based portfolio — including the OSSIFY/Ossif-i bone graft line, resorbable membranes (CollaShield, GingiDerm), resorbable sutures (Cytoflex-SE), amniotic tissue products (AmnioGain), and clinician co-developed procedure kits (e.g., Dr. Frawley Signature Kit) — that is consumed in socket preservation, ridge augmentation, guided tissue regeneration, and related periodontal and implant procedures performed by periodontists, oral surgeons, and implant dentists in the United States.

The company's core technology is proprietary allograft tissue processing, validated by histology studies at the University of Minnesota documenting osteoinductive and regenerative characteristics, paired with regulatory credentials including AATB accreditation for tissue procurement and FDA registration for HCT/P manufacturing. The portfolio is anchored around a clinician-instructor ecosystem: products and procedure kits are developed with practicing periodontists, and adoption is reinforced through the Surgical Co-op community and recurring continuing-education programming, including the Hands-on @Home virtual training launched in 2020 and periodic live surgery events.

Commercially, Surgical Esthetics Biomedical sells exclusively through authorized dental distributors — the dominant logistics and customer-relationship backbone of the US dental supply market — rather than maintaining a direct sales force. Unit economics are consumable-driven, with SKUs such as the CollaFill Collagen Plug priced in the premium tier of the dental regenerative category (~$118 list per unit). The business is bootstrapped and founder/family-owned, with headcount in the 11-50 range, no public funding rounds disclosed, and revenue derived primarily from product unit sales supplemented by CE-program engagement with the clinical community.

Name

Surgical Esthetics Biomedical

Legal name

Surgical Esthetics Biomedical Technologies, Inc.

Website

https://surgicalesthetics.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Dental Regenerative Biomaterials

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Dental Equipment and Supplies Manufacturing (339114)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industries

Dental Implant Placement (Surgical Implantology) (HLABACAE), Dental Implant Surgery & Bone Grafting (HLABAEAB)

Keywords

• Dental regenerative biomaterials
• Bone allograft products
• Collagen membranes
• Dental implant supplies
• Periodontal graft solutions

Headquarters

HQ city

Northridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Others

Revenue model

1. Dental Biomaterial Product Sales: Surgical Esthetics generates revenue primarily through the sale of premium dental regenerative biomaterials — bone allografts, xenografts, collagen membranes, PTFE membranes, sutures, instruments, and amnion-chorion products — exclusively via authorized dental distributors. Prices are quoted through dealers; the company does not sell directly to end-user dentists.
2. Clinical Education & Courses: The company runs a Surgical Co-op continuing education (CE) program offering courses, webinars, lunch-and-learn sessions, and live surgery events. Partner institutions include Brighter Way Dental Center, Wehrle Implant Immersion Course (WIIC), Foundation Implant Training (FIT), and Restorative Driven Implants (RDI). Revenue from course tuition is processed directly by Surgical Esthetics.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Surgical Esthetics Biomedical manufactures and distributes premium dental regenerative biomaterials including bone allografts (OSSIFY), collagen and PTFE membranes, sutures, acellular dermis, and amnion-chorion products. The company processes human allograft tissue using proprietary technology and sells exclusively through authorized dental distributors to general dentists and specialists performing implant placement, socket preservation, ridge augmentation, sinus lifts, and guided bone/tissue regeneration. The company also delivers continuing education, clinical mentorship, and the Surgical Co-op community for dental clinicians.

Differentiator

Problem solved

Functional benefit

Brands

• OSSIFY: Premium allograft product line including mineralized and demineralized bone allografts, sponge strips, and bone sheets.
• CollaShield
• Cytoflex-SE
• GingiDerm
• AmnioGain
• Dr. Frawley Signature Kit

Products and services

• OSSIFY Bone Allograft Product Line

Quantifiable outcome

• Histological analysis by the University of Minnesota Hard Tissue Research Lab demonstrated 100% vital bone formation with no residual graft particles after 4 months of healing using OSSIFY Mineralized Cancellous allograft
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• Brighter Way Dental CenterminorStrategic or Co-development PartnerNon-profit organization providing dental/implant surgery care to underserved communities (Veterans, unhoused, survivors of domestic violence). Surgical Esthetics supports Brighter Way as a charitable course partner, hosting educational events at their facility. The organization's state-of-the-art Dental/Implant Surgery Center serves as a training venue.
• Wehrle Implant Immersion Course (WIIC)coreStrategic or Co-development PartnerDr. Michael Wehrle founded WIIC as a premier implant training institution. Students receive pre-operative CBCT planning and post-operative CBCT review. Case matching to student skill levels. Surgical Esthetics is listed as a course partner, providing biomaterials and clinical support for live surgical training.
• Foundation Implant Training (FIT)coreStrategic or Co-development PartnerFIT is a prosthetically-driven implant training program for general dentists. Focuses on smart case selection, ideal placement, and surgical/restorative principles. Surgical Esthetics provides product support and is recognized as a partner organization in course delivery.
• Restorative Driven Implants (RDI)coreStrategic or Co-development PartnerRDI delivers training built by general practicing dentists for general practicing dentists. The Success Formula focuses on strategic clinical decision-making and confident delivery. Surgical Esthetics is a recognized course partner providing biomaterial support.
• Hard Tissue Research Lab, University of MinnesotacoreStrategic or Co-development PartnerConducted independent histological analysis of Surgical Esthetics' OSSIFY Mineralized Cancellous allograft. Results (100% vital bone, no residual graft particles) published in Compendium, April 2021. This third-party validation is a cornerstone of the company's evidence-based marketing.
• AEGIS Dental Network (Compendium Journal)minorStrategic or Co-development PartnerPublished clinical case study: 'Socket Preparation for Delayed Implant Placement Using a Mineralized Cancellous Allograft' in Compendium (April 2021), authored by expert clinicians using Surgical Esthetics products. This peer-reviewed publication supports the company's quality claims.
• Surgenex (Tissue Tracking & Processing)coreTechnology or IntegrationSurgenex provides web-based tissue tracking portals for GingiDerm and AmnioGain allograft products. Each package includes serialized stickers and forms for FDA-mandated tracking. This integration ensures regulatory compliance and chain-of-custody for human tissue products.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Geistlich Pharma: Geistlich is the global category leader in dental bone regeneration with Bio-Oss (bovine bone graft) and Bio-Gide (collagen membrane). Most directly comparable competitor to Surgical Esthetics' OSSIFY allograft and CollaShield membrane portfolio, serving the same implant dentists and specialists.
• ACE Surgical Supply: ACE Surgical supplies bone graft materials, membranes, sutures and instrumentation to dental practices — directly overlapping Surgical Esthetics' portfolio across regenerative biomaterials and surgical consumables for the same US dental customer base.
• Salvin Dental Specialties: Salvin distributes regenerative biomaterials (allografts, xenografts, membranes), sutures and surgical instruments to dental practices through a direct and dealer hybrid model — overlapping Surgical Esthetics' regenerative and instrument portfolio with similar specialist focus.
• LifeNet Health: LifeNet Health runs one of the largest AATB-accredited tissue banks and supplies dental allograft products (e.g., OraGraft) to dental practices and specialists. Directly comparable on tissue processing, regulatory certification, and dental regenerative product line.
• Osteogenics Biomedical: Osteogenics is a regenerative products specialist offering bone allografts, PTFE and collagen membranes (Cytoplast), and suture products to dental specialists and GPs — a focused direct peer competing on similar evidence-based positioning.

Emerging players

• Snoasis Medical: Snoasis Medical produces amnion-chorion and placental tissue products used in dental regenerative procedures — direct overlap with Surgical Esthetics' AmnioGain line and similar evidence-led, niche positioning to specialists.

Broad incumbents

• Integra LifeSciences: Integra LifeSciences sells regenerative and surgical products including dental-related allografts and dermis (e.g., via its regenerative tissue portfolio). A broad medical device incumbent whose dental regenerative line competes for specialist and GP accounts.
• Dentsply Sirona: Dentsply Sirona is a global dental products conglomerate whose regenerative and implant consumables overlap with Surgical Esthetics' portfolio. Much larger, but regenerative is one of many categories rather than a focused niche.
• BioHorizons (Henry Schein): BioHorizons (now part of Henry Schein) supplies dental implants alongside regenerative biomaterials to specialists. Comparable product breadth and same dental distribution channel; much larger scale and parent-company backing.
• ZimVie (Zimmer Biomet Dental): ZimVie offers RegenerOss bone graft substitutes and a broad dental implant and regenerative portfolio under the legacy Zimmer Biomet Dental business. Larger, listed incumbent competing against Surgical Esthetics across regenerative and implant workflows, especially in specialist accounts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/surgicalesthetics
• Xx.com/surgclesthetics
• Facebookfacebook.com/surgicalesthetics
• LinkedInlinkedin.com/company/surgical-esthetics

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surgical Esthetics Biomedical